145 related articles for article (PubMed ID: 33798593)
1. Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced Status Epilepticus.
Loughery TN; Whitten KA; Acon-Chen C; Shih TM
Toxicol Appl Pharmacol; 2021 May; 419():115515. PubMed ID: 33798593
[TBL] [Abstract][Full Text] [Related]
2. Seizure suppression and neuroprotection in soman-exposed rats following delayed intramuscular treatment of adenosine A
Keith ZM; Munoz C; Acon-Chen C; Shih TM
Toxicol Appl Pharmacol; 2024 Jul; 488():116970. PubMed ID: 38777098
[TBL] [Abstract][Full Text] [Related]
3. A novel genetically modified mouse seizure model for evaluating anticonvulsive and neuroprotective efficacy of an A
Shih TM
Toxicol Appl Pharmacol; 2023 Apr; 464():116437. PubMed ID: 36849019
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of adenosine A1 receptor agonists as neuroprotective countermeasures against Soman intoxication in rats.
Meads KL; Thomas TP; Langston JL; Myers TM; Shih TM
Toxicol Appl Pharmacol; 2021 Apr; 416():115466. PubMed ID: 33631229
[TBL] [Abstract][Full Text] [Related]
5. Hypothermia as potential therapeutic approach to attenuating soman-induced seizure, neuropathology, and mortality with an adenosine A
Munoz C; Acon-Chen C; Keith ZM; Shih TM
Neuropharmacology; 2024 Aug; 253():109966. PubMed ID: 38677446
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Evaluation of A1 Adenosine Agonists as Novel Anticonvulsant Medical Countermeasures to Nerve Agent Intoxication in a Rat Soman Seizure Model.
Thomas TP; Wegener A; Shih TM
Neurotox Res; 2019 Aug; 36(2):323-333. PubMed ID: 31069755
[TBL] [Abstract][Full Text] [Related]
7. Learning and memory function preserved by delayed A
Harkins J; Langston J; Keith ZM; Munoz C; Acon-Chen C; Shih TM
Neuropharmacology; 2024 Aug; 253():109983. PubMed ID: 38704023
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neuropathology in rats following status epilepticus induced by diisopropylfluorophosphate and soman.
Rojas A; McCarren HS; Wang J; Wang W; Abreu-Melon J; Wang S; McDonough JH; Dingledine R
Neurotoxicology; 2021 Mar; 83():14-27. PubMed ID: 33352274
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat.
Gore A; Neufeld-Cohen A; Egoz I; Baranes S; Gez R; Efrati R; David T; Dekel Jaoui H; Yampolsky M; Grauer E; Chapman S; Lazar S
Toxicol Appl Pharmacol; 2021 May; 419():115519. PubMed ID: 33823148
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure.
Prager EM; Aroniadou-Anderjaska V; Almeida-Suhett CP; Figueiredo TH; Apland JP; Braga MF
Neurotoxicology; 2013 Sep; 38():84-90. PubMed ID: 23817175
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of central A1 adenosine receptors suppresses seizure and neuropathology in a soman nerve agent seizure rat model.
Thomas TP; Shih TM
Toxicol Mech Methods; 2014 Sep; 24(6):385-95. PubMed ID: 24785252
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats.
Acon-Chen C; Koenig JA; Smith GR; Truitt AR; Thomas TP; Shih TM
Toxicol Mech Methods; 2016 Jun; 26(5):378-88. PubMed ID: 27329284
[TBL] [Abstract][Full Text] [Related]
13. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.
White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M
Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444
[TBL] [Abstract][Full Text] [Related]
14. Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure.
Tetz LM; Rezk PE; Ratcliffe RH; Gordon RK; Steele KE; Nambiar MP
Toxicol Ind Health; 2006 Jul; 22(6):255-66. PubMed ID: 16924957
[TBL] [Abstract][Full Text] [Related]
15. Preventing Long-Term Brain Damage by Nerve Agent-Induced Status Epilepticus in Rat Models Applicable to Infants: Significant Neuroprotection by Tezampanel Combined with Caramiphen but Not by Midazolam Treatment.
De Araujo Furtado M; Aroniadou-Anderjaska V; Figueiredo TH; Pidoplichko VI; Apland JP; Rossetti K; Braga MFM
J Pharmacol Exp Ther; 2024 Jan; 388(2):432-450. PubMed ID: 37739807
[TBL] [Abstract][Full Text] [Related]
16. Comparison of neuroprotective effects induced by alpha-phenyl-N-tert-butyl nitrone (PBN) and N-tert-butyl-alpha-(2 sulfophenyl) nitrone (S-PBN) in lithium-pilocarpine status epilepticus.
Peterson SL; Purvis RS; Griffith JW
Neurotoxicology; 2005 Dec; 26(6):969-79. PubMed ID: 15890407
[TBL] [Abstract][Full Text] [Related]
17. Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure.
Figueiredo TH; Aroniadou-Anderjaska V; Apland JP; Rossetti K; Braga MF
Exp Biol Med (Maywood); 2023 Apr; 248(7):612-623. PubMed ID: 37300407
[TBL] [Abstract][Full Text] [Related]
18. Differential neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in lithium-pilocarpine status epilepticus.
Peterson SL; Purvis RS; Griffith JW
Neurotoxicology; 2004 Sep; 25(5):835-47. PubMed ID: 15288514
[TBL] [Abstract][Full Text] [Related]
19. Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital.
Jackson C; Ardinger C; Winter KM; McDonough JH; McCarren HS
J Pharmacol Toxicol Methods; 2019; 97():1-12. PubMed ID: 30790623
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats.
Apland JP; Aroniadou-Anderjaska V; Figueiredo TH; Prager EM; Olsen CH; Braga MFM
Neurotox Res; 2017 Nov; 32(4):694-706. PubMed ID: 28776308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
